Liz Homans

Lyell Immunopharma

Liz Homans has served as our Chief Executive Officer and member of our board of directors since August 2020. From September 2018 to August 2020, she served as our
president and the operational lead as we grew in size, scope and ambition. From December
2007 to May 2018, Liz served in multiple senior leadership positions at
Genentech, including vice president, U.S. sales and marketing leader for Breast Cancer,
vice president, U.S. sales and marketing leader for Xolair, vice president, global regulatory operations leader and vice president, global product strategy, HER2 Franchise. From May 2004 through November 2007, Liz served as executive director, Project Leadership and Portfolio Management at Jazz Pharmaceuticals, Inc. Liz received an M.B.A. from Columbia University in the City of New York and a B.A. in German and Economics from Bates University

Year appointed: 2020